The use of argon beam coagulation in treating vulvar intraepithelial neoplasia III: a retrospective review.

UNLABELLED: Argon beam coagulation (ABC) has unique properties which make it suitable for the local treatment of superficial epithelial disorders such as vulvar intraepithelial neoplasia (VIN III). OBJECTIVE: To evaluate argon beam coagulation in treating multifocal VIN III. METHODS: Argon beam coagulation was used in twenty-nine patients. ABC was set at 80 W, 7 L/min. All patients were given 1% silvadene cream to apply to vulva. Patients had follow-up appointments two weeks and six weeks postoperatively. Patients were followed every three to six months for the subsequent year. RESULTS: 2 of 29 (6.8%) experienced moderate pain within the first two weeks postoperatively requiring prescriptions for perocet. 2 of 29 (6.8%) had yeast infection requiring diflucan. Mean follow-up time was 34.9 months (11.7-37.4). 15 of 29 (51.7%) had no recurrence within the follow-up period. 14 of 29 (48.3%) recurred within the follow-up period. The mean time to recurrence is 23.2 months. CONCLUSION: This small retrospective review is the first to evaluate argon beam coagulation in treating multifocal VIN III. This review indicates that ABC is comparable to other vulva organ conserving therapies. ABC retains cosmesis, and form of the vulva. This is a major advantage over surgery. Repeat treatments are also possible, which is important in a condition such as VIN, which tends to be multifocal and recurrent.

Plasma Device Functions and Tissue Effects in the Female Pelvis-A Systematic Review.

Medical use of (non-)thermal plasmas is an emerging field in gynaecology. However, data on plasma energy dispersion remain limited. This systematic review presents an overview of plasma devices, fields of effective application, and impact of use factors and device settings on tissues in the female pelvis, including the uterus, ovaries, cervix, vagina, vulva, colon, omentum, mesenterium, and peritoneum. A search of the literature was performed on 4 January 2023 in the Medline Ovid, Embase, Cochrane, Web of Science, and Google Scholar databases. Devices were classified as plasma-assisted electrosurgery (ES) using electrothermal energy, neutral argon plasma (NAP) using kinetic particle energy, or cold atmospheric plasma (CAP) using non-thermal biochemical reactions. In total, 8958 articles were identified, of which 310 were scanned, and 14 were included due to containing quantitative data on depths or volumes of tissues reached. Plasma-assisted ES devices produce a thermal effects depth of <2.4 mm. In turn, NAP effects remained superficial, <1.0 mm. So far, the depth and uniformity of CAP effects are insufficiently understood. These data are crucial to achieve complete treatment, reduce recurrence, and limit damage to healthy tissues (e.g., prevent perforations or preserve parenchyma). Upcoming and potentially high-gain applications are discussed, and deficits in current evidence are identified.

Management of Ruptured Subcapsular Liver Hematoma as a Result of Hemolysis, Elevated Liver Enzyme, and Low Platelet Syndrome in a Rural Facility.

Subcapsular liver hematoma is a rare complication of hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome. This case depicts a previously healthy 27-year-old primigravida at 39 weeks' gestation who presented with severe abdominal pain and was diagnosed with HELLP syndrome based on vital signs and laboratory values. While arranging transport to a regional perinatal care facility she became acutely unstable with maternal hypotension and resultant fetal bradycardia. An emergent cesarean section was performed and a ruptured subcapsular liver hematoma was diagnosed intraoperatively. She was successfully managed with supportive care and surgical intervention and was discharged from the hospital on postoperative day 6. Here we review the indications and methods of conservative and surgical management of subcapsular liver hematoma as a result of HELLP syndrome.

Feasibility, safety and efficacy of argon beam coagulation in robot-assisted partial nephrectomy for solid renal masses ≤ 7 cm in size.

One of the most important steps of the partial nephrectomy (PN) is hemostatic control of tumor bed which also effects the warm ischemia time (WIT). Argon beam coagulation (ABC) for decades is a well-known method for surface controls during major open surgical sites. This study aimed to compare peri- and postoperative relevant parameters in patients with ABC or internal renorrhaphy (IR) during robot-assisted partial nephrectomy (RAPN). One hundred seventy patients with ≤ 7 cm tumors, who underwent RAPN at our institutions, were included in this retrospective study. Tumor bed was controlled by either IR or by ABC after closing isolated overt collecting system defects. No additional IR was performed in patients with ABC. Estimated blood loss (EBL), WIT, estimated glomerular filtration rate (eGFR) change, on- vs. off-clamp procedure as well as Clavien-Dindo > 2 complications in both groups were compared. Eighty-seven (51.1%) patients had ABC and 83 (48.9%) had IR as their tumor bed control method. Tumor size, side and RENAL nephrometry score in both groups were similar. Mean warm ischemia time (WIT) was 20.8 min in ABC group and 23.8 min in IR group (p = 0.03). In 4-7 cm tumors, WIT was 19.9 min in ABC group while 26.6 min in IR group (p = 0.026). eGFR change from baseline and EBL favored ABC in entire cohort as well as in 4-7 cm tumors with statistical significance. There were more off-clamp procedures with ABC in ≤ 4 cm tumors. No ABC specific complications were observed. Within 2 years of follow-up, no patient developed recurrences. The control of the tumor base with ABC during RAPN shortens the warm ischemia times significantly compared to IR. Besides, ABC had better EBL and GFR changes outcomes. With close monitoring of intra-abdominal pressure and frequent venting, disturbing complications of ABC could completely be avoided. ABC was found to be feasible, safe and effective during RAPN.

[A probable fatal argon gas embolism during resection of a cutaneous biliary fistula - a case report]. / Provável embolia letal por gás argônio durante ressecção de fístula cutânea biliar ­ relato de caso.

BACKGROUND: The Argon Beam Coagulator (ABC) achieves hemostasis but has potential complications in the form of argon gas embolisms. Risk factors for embolisms have been identified and ABC manufacturers have developed guidelines for usage of the device to prevent embolism development. CASE REPORT: A 49 year-old male with history of recurrent cholangiocarcinoma status post resection presented for resection of a cutaneous biliary fistula. Shortly after initial use of the ABC, the patient underwent cardiac arrest. After resuscitation, air bubbles were observed in the left ventricle via Transesophageal Echo (TEE). CONCLUSION: Although argon embolisms have been described more commonly during laparoscopies, this patient most likely experienced an argon gas embolism during an open resection of a cutaneous biliary fistula via the biliary tract or vein with possible transpulmonary passage of the embolism. Consequently, a high degree of suspicion should be maintained for an argon gas embolism during ABC use in laparoscopic, open, and cutaneous surgeries.

A new application for argon beam coagulation: the thymoma patient with pleural recurrence.

Thymomas are enigmatic tumors for which surgical resection is the mainstay of treatment. However, there are still many debates about resected thymomas with pleural recurrence. Repetitive operations for thymomas involving pleural recurrence are still the treatment of choice. Herein, we present a case with a suitable performance status for re-operation with a new application for argon beam coagulation. Both our experience and the currently available evidence suggest that surgical resection could be considered for patients with advanced thymomas, even for patients with locally advanced or Masaoka-Koga stage IV thymomas. Multimodality or multimodal, treatments resulted in better oncological outcomes for these patients. In this case, we proved that the new application of argon beam coagulation for a thymoma patient with pleural recurrence is safe and feasible. Additional evidence should be collected, and patients should be followed to assess long-term benefits.

Management of a Tibial Plafond Lung Cancer Metastasis Using an Intramedullary Hindfoot Fusion Nail.

Metastatic disease to the tibial plafond is rare with few reports in the literature. No consensus exists regarding surgical reconstruction of large structural defects of the ankle due to these lesions, as each treatment must be tailored to the individual patient's goals and prognosis. Cancer metastases pose a unique challenge to limb salvage as there is often bone loss and poor soft tissue quality combined with the need for postoperative adjuvant therapy. The goal of surgery is to obtain early weightbearing, pain relief, and a durable reconstruction that will outlive the patient. In this report, we present the case of an intraarticular fracture of the tibial plafond with severe bone loss due to a lung carcinoma metastasis. The patient was successfully treated with en bloc tumor excision, curettage, argon beam coagulation, tibiotalocalcaneal arthrodesis using an intramedullary hindfoot fusion nail, and bone cementation with postoperative chemotherapy and radiation. One year after surgery, the patient was able to bear full weight on the extremity without a brace or assistive device and had no pain in the ankle with no local tumor recurrence. LEVELS OF EVIDENCE: Level V: Expert opinion.

Hump-like giant desmoid tumor of the chest: a postresectional reconstruction challenge.

Desmoid tumors (DT) are rare neoplasms with unknown etiology arising from musculoaponeurotic structures. Chest wall localization is uncommon and has been associated with high recurrence rate unless radical resection with negative margins is carried out. Postresectional reconstruction can be challenging in presence of giant lesions and might require adoption of complex reconstruction methods including use of well vascularized muscle flaps. We present a case of giant hump-like recurrent chest wall DT, which was radically resected following placement of multiple subcutaneous silicon tissue expanders, to gain redundant skin, which eventually allowed in conjunction with two transposition, cutaneous-adipose flaps, harvested from the upper gluteal region, an optimal reconstruction of the large postresectional defect.

A probable fatal argon gas embolism during resection of a cutaneous biliary fistula - a case report / Provável embolia letal por gás argônio durante ressecção de fístula cutânea biliar - relato de caso

Abstract Background: The Argon Beam Coagulator (ABC) achieves hemostasis but has potential complications in the form of argon gas embolisms. Risk factors for embolisms have been identified and ABC manufacturers have developed guidelines for usage of the device to prevent embolism development. Case report: A 49 year-old male with history of recurrent cholangiocarcinoma status post resection presented for resection of a cutaneous biliary fistula. Shortly after initial use of the ABC, the patient underwent cardiac arrest. After resuscitation, air bubbles were observed in the left ventricle via Transesophageal Echo (TEE). Conclusion: Although argon embolisms have been described more commonly during laparoscopies, this patient most likely experienced an argon gas embolism during an open resection of a cutaneous biliary fistula via the biliary tract or vein with possible transpulmonary passage of the embolism. Consequently, a high degree of suspicion should be maintained for an argon gas embolism during ABC use in laparoscopic, open, and cutaneous surgeries.

Resumo Introdução: A Coagulação por Feixe de Argônio (CFA) promove hemostasia, mas pode levar a complicações na forma de embolia por gás argônio. Os fatores de risco para embolias foram identificados e os fabricantes de aparelhos de CFA desenvolveram diretrizes para o uso do dispositivo para impedir a ocorrência de embolia. Relato de caso: Paciente masculino de 49 anos com história de colangiocarcinoma recorrente pós-ressecção foi submetido à ressecção de fístula cutâneo-biliar. Logo após o início do uso do aparelho de CFA, o paciente apresentou parada cardíaca. Após o retorno da atividade cardíaca, a Eecocardiografia Transesofágica (ETE) detectou bolhas de ar no ventrículo esquerdo. Conclusões: Embora a embolia associada ao argônio seja mais frequentemente descrita durante laparoscopia, este paciente mais provavelmente apresentou embolia provocada pelo argônio durante cirurgia aberta para ressecção de fístula cutâneo-biliar, após o argônio ganhar acesso à circulação sanguínea através das vias biliares ou da veia biliar e possível passagem do êmbolo pela circulação pulmonar. Desta maneira, deve-se suspeitar de embolia por argônio, de forma judiciosa, durante o uso de CFA em procedimento cirúrgico laparoscópico, aberto ou cutâneo.

Application and advantages of sutureless technique via argon beam coagulator in partial nephrectomy for renal tumors / 上海交通大学学报（医学版）

Objective • To explore the safety and feasibility of using sutureless technique of argon beam coagulator in laparoscopic partial nephrectomy. Methods • A total of 10 patients receiving laparoscopic partial nephrectomy with argon beam coagulator in Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine from October 2016 to October 2017 were selected. The clinical efficacy and safety of the operation was retrospectively analyzed. Results • The average age of the 10 patients was 50.4 (24.0-73.0) years, the average size of the tumor was 2.1 (1.5-2.5) cm, and the average RENAL score was 5. All of the 10 patients underwent intraoperative renal artery occlusion. Intraoperative scissors were used to completely remove the tumor and remove the tumor bed after the resection. Then the argon beam coagulator was repeatedly used for hemostasis. After hemostasis was completed, the hemostatic gauze was covered on the surface of the tumor bed. The mean operation time was 95.0 (60.0-108.0) min, and the average thermal ischemia time of the renal artery occlusion was 7.8 (5.5-10.0) min. The average blood loss was 86 (50-150) mL during the operation. The average decrease of hemoglobin was 11.8 (3.0-22.0) g/L on the first day after operation. The mean indwelling catheterization time was 2.7 (1.5-3.5) d, the average time of hospitalization was 5.2 (4.0-7.0) d, the extraction time of drainage tube after operation was 2.6 (1.0-4.0) d, and the flow rate was 38.5 (10.0-80.0) mL. Conclusion • Argon knife spray coagulation has good efficacy and safety in patients with renal tumor renal resection, especially for some exophytic renal tumors, which has short operation time, less damage of hot ischemia, good postoperative effect, no increase in hospitalization time after surgery, reduced economic burden of the patients, being worthy of popularization and application.

Argon Beam Coagulator as an Adjunct to Surgery in the Treatment of Drug-Resistant Ventricular Tachycardia. Basic Experiments and Clinical Application / 日本心臓血管外科学会雑誌

Surgery and cryoablation have been the preferred method for treating drug resistant ventricular tachycardia (VT). Cryoablation, the therapeutic usefulness of which has been documented in many reported studies, is nevertheless not free from technical difficulaties. The advent of Bard^® System 6000 Argon beam coagulator (ABC) as a new procedure alternative to cryoablation offered us a hope for solving problems with conventionally used techniques. Preliminary experiments with this device on dog myocardium permitted us to determine therapeutically adequate irradiation time and depth of cauterization and to locate an optimum area of myocardium to be coagulated. Based on these experiences, an attempt was made to use ABC as an adjunct to surgery in the surgical treatment of 4 patients with monofocal non-ischemic VT. In 1 of these 4 patients, VT disappeared postoperatively, making use of antiarrythmia drugs quite unnecessary, while in the remaining 3, a marked diminution of ventricular arrhythmia with a consequent reduction of drug dosage was achieved, use of the device thus being judged to be beneficial. These results led to the conclusion that ABC will provide a valuable adjunct to operation in selected cases of VT and, if the probe and other appliances are further refined, can reasonably be anticipated to be used as frequently as cryoablation.